-
SOCIAL AND STRUCTURAL DETERMINANTS OF BUPRENORPHINE ADHERENCE AMONG INDIVIDUALS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
THE COST OF INEQUITY: ESTIMATING THE IMPACT OF DELAYED ACCESS TO NEOADJUVANT PERTUZUMAB IN CANADA
Mar 18, 2026, 21:38 PM -
QUALITY FIRST: MODERNIZING THE NURSING CURRICULUM FOR ACCREDITED HEALTHCARE
Mar 18, 2026, 21:38 PM -
PREPARING FOR THE NEXT ACCESS PARADIGM: TRANSITIONING FROM A REBATE-DOMINANT MARKET TO EU-STYLE EVIDENCE-BASED VALUE TO MAXIMIZE US PAYER COVERAGE
Mar 18, 2026, 21:38 PM -
ESTIMATION OF HEALTH-STATE UTILITY VALUES IN PHENYLKETONURIA (PKU), VIA CLINICAL-EXPERT PROXY ASSESSMENT WITH A GENERIC MEASURE (SF-12V2) OF PATIENT-REPORTED IMPACTS FROM A DISEASE-SPECIFIC MEASURE (PKU-QOL): INTERIM RESULTS
Mar 18, 2026, 21:38 PM -
WHEN THE TAIL WAGS THE DOG: RETHINKING PARTITIONED SURVIVAL MODELLING IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
IMPACT OF A DIGITAL CARDIOVASCULAR MANAGEMENT PROGRAM ON HEALTHCARE COSTS AND UTILIZATION IN PATIENTS WITH HEART FAILURE: A PROPENSITY-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
PREVALENCE AND HEALTHCARE BURDEN OF COMPLICATED URINARY TRACT INFECTIONS AMONG HOSPITALIZED PATIENTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
PROJECTED IMPACT OF PERSONALIZED MRNA NEOANTIGEN CANCER VACCINES IN MEDICARE: A SCENARIO ANALYSIS USING TRIAL EFFICACY AND LINKED DATA POPULATION ESTIMATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD COST-EFFECTIVENESS AND OPPORTUNITY COSTS OF ANTI-IL-17/23 VERSUS ANTI-TNF? THERAPIES FOR PSORIASIS USING DLQI
Mar 18, 2026, 21:38 PM -
CHARACTERIZING GLOBAL ISPOR STUDENT PARTICIPATION: A NORTH AMERICA VS. REST OF WORLD COMPARISON
Mar 18, 2026, 21:38 PM -
IMPORTANCE OF INTERMEDIATE CLINICAL ENDPOINTS (ICES) IN PROSTATE CANCER (PC) FOR PATIENTS: A CLUSTER ANALYSIS
Mar 18, 2026, 21:38 PM -
ACCOUNTING FOR RISK-AVERSION IN HEALTH TECHNOLOGY ASSESSMENT: UTILITY ESTIMATION ACROSS MULTIPLE HEALTH INDEXES IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
INSIGHTS INTO RANGE OF MOTION (ROM) AND PHYSICAL FUNCTION (PF) CHANGES EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: RESULTS FROM EXIT INTERVIEWS
Mar 18, 2026, 21:38 PM -
CONFIDENCE INTERVALS FOR EVENT-BASED NUMBER NEEDED TO TREAT: A PRACTICAL APPROACH FOR HEALTH ECONOMIC EVALUATION OUTPUTS
Mar 18, 2026, 21:38 PM -
ECONOMIC OUTCOMES, REAL-WORLD ADHERENCE PATTERNS AND PREDICTIVE MODELING OF MIGRAINE PROPHYLAXIS: A RETROSPECTIVE COHORT STUDY OF TRIPTANS, BETA-BLOCKERS, AND COMBINATION THERAPY
Mar 18, 2026, 21:38 PM -
ENSURING STUDY VALIDITY TO INFORM HEALTH TECHNOLOGY ASSESSMENTS GLOBALLY
Mar 18, 2026, 21:38 PM -
REAL-WORLD ADOPTION, BARRIERS, ARTIFICIAL INTELLIGENCE INTEGRATION, AND FUTURE READINESS OF ROBOTIC-ASSISTED SURGERY (RAS) IN CHINA
Mar 18, 2026, 21:38 PM -
IDENTIFYING PREDICTORS OF HIGH-COST CARE IN GENERALIZED PUSTULAR PSORIASIS: INSIGHTS FROM U.S. REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
DIFFERENCES IN THE DIETARY HABITS AND RISK FACTORS FOR METABOLIC DISEASES BETWEEN WESTERN AND EASTERN EUROPE
Mar 18, 2026, 21:38 PM
